Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CYT 005 AllQbG10

Next Previous
X
Search
Drug Profile

CYT 005 AllQbG10

Alternative Names: CYT003-QbG10 + approved allergan extract; CYT003-QbG10 combination vaccine - Cytos Biotechnology; CYT005-AllQbG10

Latest Information Update: 23 Feb 2017

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cytos Biotechnology
  • Class Allergy immunotherapies; Antiallergics; Virus-like particle vaccines
  • Mechanism of Action Th1 cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Allergic asthma; Allergic conjunctivitis; Perennial allergic rhinitis; Seasonal allergic rhinitis

Most Recent Events

  • 10 Jul 2008 Efficacy and adverse events data from a Phase-II trial in Perennial allergic rhinitis released by Cytos Biotechnology
  • 29 Nov 2007 Cytos Biotechnology initiates enrolment in a phase II trial for perennial allergic rhinitis
  • 17 May 2007 Results from a phase IIa clinical trial in patients with allergic rhinitis have been added to the adverse events and Obstructive Airways Disease therapeutic trials sections

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top